# Opus Genetics, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 16:11 ET
- Period: 2026-06-16
- Accession: 0001140361-26-025440
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036126025440/ef20076319_form8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036126025440/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036126025440/ef20076319_form8k.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-025440. Last ingested by Listed: Nov 5, 2026, 16:37 ET. No prices; not investment advice.